Patrick Soon-Shiong
Networth: 6 Billion
Country: United States
Industry: Healthcare
Medical doctor Patrick Soon-Shiong invented the cancer drug Abraxane. It became a blockbuster thanks to its efficacy against pancreatic cancer.He sold his drug companies Abraxis in 2010 and American Pharmaceutical Partners in 2008 for a combined $9.1 billion. He took his cancer drug maker NantKwest public in 2015 and his biotech startup NantHealth public in 2016.He owns NantWorks, a network of health startups, and has stakes in media firm Tribune Publishing and the Los Angeles Lakers.He bought the Los Angeles Times and San Diego Tribune for $500 million in June 2018.In May 2020, Soon-Shiong's ImmunityBio was selected for the federal government's "Operation Warp Speed" to help quickly develop a Covid-19 vaccine.
Financial Assets
Ticker: MDRX-US
Shares: 5,416,000
Ticker: BNTC-US
Shares: 293,000
Ticker: BMY-US
Shares: 13,592,000
Ticker: CELG-US
Shares: 0
Ticker: CELGZ-US
Shares: 0
Ticker: DCTA-GB
Shares: 17,603,000
Ticker: IBRX-US
Shares: 307,639,000
Ticker: IBRX-US
Shares: 900,000
Exercise Price: $25.00
Ticker: JAKK-US
Shares: 0
Ticker: LMNL-CA
Shares: 0
Exercise Price: $0.36
Ticker: NH-US
Shares: 66,803,000
Ticker: RDNT-US
Shares: 891,000
Ticker: SRNE-US
Shares: 0
Ticker: TPCO-US
Shares: 0